Product NDC: | 0071-0350 |
Proprietary Name: | Nardil |
Non Proprietary Name: | Phenelzine Sulfate |
Active Ingredient(s): | 15 mg/1 & nbsp; Phenelzine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0071-0350 |
Labeler Name: | Parke-Davis Div of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011909 |
Marketing Category: | NDA |
Start Marketing Date: | 19610609 |
Package NDC: | 0071-0350-60 |
Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0350-60) |
NDC Code | 0071-0350-60 |
Proprietary Name | Nardil |
Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0350-60) |
Product NDC | 0071-0350 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phenelzine Sulfate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19610609 |
Marketing Category Name | NDA |
Labeler Name | Parke-Davis Div of Pfizer Inc |
Substance Name | PHENELZINE SULFATE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |